Hepatitis Monthly
Official Journal of Research Center for Gastroenterology and Liver Diseases
Scopus by Title (Ref)
1. Genetic variants underlying precancerous conditions of hepatocellular carcinoma
- Guerrero J.J.G. , et al.
3. Hepatitis C virus infection in Iran: A review of current prevalence and preventive strategies from a developing country
- Tantuoyir M.M. , et al.
4. Sub-genotypes of hepatitis C virus in the Middle East and North Africa: Patterns of distribution and temporal changes
- Athamneh R.Y. , et al.
5. HCV Genotype Distribution Among People Who Inject Drug in Turkey: Findings from Multicenter and Cross-Sectional Study
- Dilbaz N. , et al.
6. Prevalence of Hepatitis C Infection and its Genotypes in Suspected Hemodialysis Patients, Southwest of Iran
- Jamalidoust M. , et al.
7. Hepatitis C-induced hepatocellular carcinoma in the middle east
- Al-Busafi S.A. , et al.
8. The frequency of hepatitis C virus genotypes with chronic hepatitis C referred to Nikopour clinic in Yazd
- Mousavi S.A. , et al.
9. Prevalence of Naturally Occurring Resistance Associated Substitutions in NS3/4AProtease Inhibitors in Iranian HCV/HIV Infected Patients
- Baesi K. , et al.
10. Cost-utility Analysis of Second-generation Direct-acting Antivirals for Hepatitis C
- Goudarzi Z. , et al.
11. Changes in the distribution pattern of hepatitis c virus genotypes among chronic hepatitis patients: A cross-sectional study
- Kazemi R. , et al.
12. Seronegative occult hepatitis C infection among hemodialysis patients: A prevalence study
- Mahmoudvand S. , et al.
13. Prevalence of Naturally-Occurring NS5A and NS5B Resistance-Associated Substitutions in Iranian Patients With Chronic Hepatitis C Infection
- Rahimi P. , et al.
14. Variations in IL-22, IL-27 and IL-35 serum levels in untreated and treated hepatitis C patients
- Taghinejad A. , et al.
15. Resistance-associated substitutions (RASs) to HCV direct-acting antivirals (DAAs) at baseline of treatment in thalassemia patients: a referral center study
- Safarnezhad Tameshkel F. , et al.
16. Molecular epidemiology of Hepatitis B virus, Hepatitis C virus, and Hepatitis D virus in general population of Afghanistan
- Husseini A.A. , et al.
17. HCV genotypes and their determinative role in hepatitis C treatment
- Keikha M. , et al.
18. Epidemiology of hepatitis c virus infection among 1,959 patients in shiraz, southern iran, between 1991 and 2016
- Babaei A.H. , et al.
19. Prevalence of hepatitis c virus genotypes in hiv positive patients referring to the consultation center for behavioral diseases, Sanandaj, Iran
- Amini S. , et al.
20. Identifying genotype profile of chronic hepatitis C infection in Southwest Iran
- Khadempour-Arani H. , et al.
21. Signature of natural resistance in NS3 protease revealed by deep sequencing of HCV strains circulating in Iran
- Cuypers L. , et al.
22. Prediction of HCV load using genotype, liver biomarkers, and clinical symptoms by a mathematical model in patients with HCV infection
- Basharkhah S. , et al.
23. Prevalence and genetic diversity of HCV among HIV-1 infected individuals living in Ahvaz, Iran
- Teimoori A. , et al.
24. Incidence, mortality, and burden of hepatitis B and C and geographical distribution in Iran during 2008-2015
- Moradi G. , et al.
25. Therapeutic vaccines of hepatitis C virus with emphasis on DNA vaccine
- Shahzamani K. , et al.